CRISPR/Cas12a-Based Ultrasensitive and Rapid Detection of JAK2 V617F Somatic Mutation in Myeloproliferative Neoplasms
Open Access
- 24 July 2021
- journal article
- research article
- Published by MDPI AG in Biosensors
- Vol. 11 (8) , 247
Abstract
The JAK2 V617F mutation is a major diagnostic, therapeutic, and monitoring molecular target of Philadelphia-negative myeloproliferative neoplasms (MPNs). To date, numerous methods of detecting the JAK2 V617F mutation have been reported, but there is no gold-standard diagnostic method for clinical applications. Here, we developed and validated an efficient Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR associated protein 12a (Cas12a)-based assay to detect the JAK2 V617F mutation. Our results showed that the sensitivity of the JAK2 V617F/Cas12a fluorescence detection system was as high as 0.01%, and the JAK2 V617F/Cas12a lateral flow strip assay could unambiguously detect as low as 0.5% of the JAK2 V617F mutation, which was much higher than the sensitivity required for clinical application. The minimum detectable concentration of genomic DNA achieved was 0.01 ng/μL (~5 aM, ~3 copies/μL). In addition, the whole process only took about 1.5 h, and the cost of an individual test was much lower than that of the current assays. Thus, our methods can be applied to detect the JAK2 V617F mutation, and they are highly sensitive, rapid, cost-effective, and convenient.Keywords
Funding Information
- National Natural Science Foundation of China (81902150, 81770200)
- National Key Research and Development Program of China (2016YFC0905102, 2017YFC1001802)
- China Postdoctoral Science Foundation (2020TQ0362)
- Natural Science Foundation of Hunan Province (2020JJ5796)
This publication has 62 references indexed in Scilit:
- Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) studyLeukemia, 2013
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial ImmunityScience, 2012
- Development of a highly sensitive method for detection of JAK2V617FJournal of Hematology & Oncology, 2011
- CRISPR interference: RNA-directed adaptive immunity in bacteria and archaeaNature Reviews Genetics, 2010
- Adaptor protein Lnk negatively regulates the mutant MPL, MPLW515L associated with myeloproliferative disordersBlood, 2007
- Comparison of whole blood vs purified blood granulocytes for the detection and quantitation of JAK2V617FLeukemia, 2007
- JAK2Exon 12 Mutations in Polycythemia Vera and Idiopathic ErythrocytosisNew England Journal of Medicine, 2007
- The Myeloproliferative DisordersNew England Journal of Medicine, 2006
- Detection of the JAK2 V617F Mutation by LightCycler PCR and Probe Dissociation AnalysisThe Journal of Molecular Diagnostics, 2006
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005